Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Nov 13, 2019 · 10-Q · 44 days after period end · 0001740797-19-000031
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Net Income | -$30.99K | -$24.13K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end
